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Abstract
Nanotechnology has facilitated the applications of a class of nanomaterials called superpar-
amagnetic iron oxide nanoparticles (SPIONs) in cancer theranostics. This is a newdiscipline
in biomedicine that combines therapy and diagnosis in one platform. The multifunctional
SPIONs,whichare capable ofdetecting,visualizing, anddestroying theneoplastic cellswith
fewer side effects than the conventional therapies, are reviewed in this chapter for
theranostic applications. The chapter summarizes thedesignparameters suchas size, shape,
coating, and target ligand functionalization of SPIONs, which enhance their ability to
diagnose and treat cancer. The review discusses the methods of synthesizing SPIONs, their
structural, morphological, andmagnetic properties that are important for theranostics. The
applications of SPIONs for drug delivery,magnetic resonance imaging, andmagnetic hyper-
thermia therapy (MHT) are included. The results of our recent MHT study on Gd-doped
SPIONas a possible theranostic agent are highlighted.We have also discussed the challenges
and outlook on the future research for theranostics in clinical settings.
Keywords: theranostics, Fe3O4 nanoparticles, MRI contrast agent, drug delivery,
magnetic hyperthermia
1. Introduction
Nanomaterials, with the size of at least one dimension ranging from a few nanometers to about
a hundred nanometers, having unique properties compared to their respective bulk materials,
are of intense research interest because of their applications in various fields of science and
technology. One of the major applications, among many of their potential applications, is in
biomedicine as platform for effective diagnosis and therapy [1–3]. The multifunctionality of
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these nanoparticles has recently led the biomedicine research in a new direction called
“Theranostics” which is the integration of diagnostic imaging and therapeutic function into a
single platform [4, 5]. Theranostic agents allow the combination of diagnosis, treatment, and
follow-up of a disease and hence are expected to contribute to personalized medicine. Among
many nanomaterials, magnetic nanoparticles (MNPs) have the potential to deliver imaging
and therapeutic agents to a specific region in the body with an external magnetic field manip-
ulation. This requires large magnetization for the MNP so that they could respond to exter-
nally applied magnetic fields at physiological temperatures. Superparamagnetic iron oxide
nanoparticles (SPIONs), such as Fe3O4 and γ-Fe2O3 nanoparticles, exhibit relatively higher
saturation magnetization with no magnetic hysteresis (zero remanence and coercivity) and
fulfill other major requirements such as low toxicity, biocompatibility, and surface functiona-
lization capabilities for theranostic applications. A number of SPIONs have undergone clinical
trials and several formulations have been approved for clinical imaging and therapeutic
applications [6]. A few examples are Lumiren for bowel imaging, Ferridex IV for liver and
spleen imaging, Combidex for lymph node metastases imaging, and Ferumoxytol for iron
deficiency therapy.
Furthermore, SPIONs can be multipurposely used for diagnosis such as magnetic resonance
imaging (MRI) and for therapeutic functions such as targeted delivery of therapeutic agents,
anticancerdrugs, siRNA,and formagnetichyperthermia (MHT) for cancer treatments. Thismakes
SPION an ideal vehicle in the development of theranostic nanomedicine [7–9]. An example of
strategy for usingmagnetic nanoparticles as a potential theranostic agent is illustrated in Figure 1.
In this chapter, we discuss the detailed background on magnetic properties of SPIONs and
their synthesis methods and surface modification for cancer diagnosis and therapy. In addi-
tion, various applications of SPION ranging from MRI contrast agent to therapeutic-targeted
drug delivery and MHTare discussed. We have also highlighted the results of our recent study
on Gd-doped SPION as a possible theranostic agent. The remainder of the chapter focuses on
the challenges and outlook on the future research for theranostics in clinical settings.
Figure 1. Schematic illustration of the therapeutic strategy using MNP. Functionalized MNPs accumulate in the tumor
tissues via the drug delivery system. MNP can be used as a tool for cancer diagnosis by MRI or for magneto-impedance
sensor. Hyperthermia can then be induced by alternating magnetic field exposure.
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2. Magnetic properties of SPION
2.1. Background
MNPs have been studied for over 50 years now due to their potential application in many
areas including biomedical sciences. As for the types of MNP, the major focus has been on iron
oxide (Fe3O4), gold-coated iron oxide (Au-Fe3O4), metallic iron (Fe), and Fe-Co and Fe-Pt
nanoparticles. In most cases, the particle size ranges from 1 to 100 nm exhibiting high surface-
to-volume ratio. As a result, they offer higher surface area for interaction with foreign objects
compared to larger particles. Many review articles have been written that focus on sensing,
drug delivery, and hyperthermia properties of these nanoparticles [10–13]. The physical, chem-
ical, and magnetic properties of MNP largely depend on synthesis method and their surface
modification, and much progress has been made in this direction to MNP of varying sizes,
shapes, composition, and core-shell designs [14–23].
The important magnetic parameters relevant to theranostic applications are saturation magne-
tization (Ms), remanent magnetization (Mr), coercivity (Hc), Curie temperature (Tc), magnetic
anisotropy energy density (K), and blocking temperature (Tb). These parameters are influenced
by the material, size, shape, composition, and core-shell (functionalization) of the nanoparticles.
Ms is the maximum value of magnetization of the material that can be achieved under the
influence of an external magnetic field, Mr is the remanent magnetization in the material after
removing the external magnetic field, Hc is the strength of the reverse magnetic field needed to
bring the remanent magnetization to zero, and K is the material property signifying the
tendency of the magnetization to orient along a certain axis of the particle. As the volume (V)
of the particles decreases, the magnetic anisotropy energy (KV) of the nanoparticle also
decreases. If the particle size is reduced below a certain critical size, it becomes a single
magnetic domain creating a giant spin called “superspin” leading to a large magnetic moment
(~10,000 Bohr magneton) on each particle. The behavior of a collection of such noninteracting
particles under an external magnetic field is determined by a competition between the mag-
netic anisotropy energy barrier (ΔE) and the thermal energy (kBT) for magnetic moment
reversal. Above a characteristic temperature called the blocking temperature, TB, their behav-
ior is very similar to that of a paramagnetic material and described as “superparamagnetism.”
The underlying physics of superparamagnetism is founded on the activation law for the
relaxation time τ of the net magnetization of the particle given by τ = το exp (ΔE/kBT), where
το is of the order of 10
9
–1012 s [24].
2.2. Effect of size, shape, and composition
Magnetic properties of materials, such as susceptibility, coercivity, and saturation magnetiza-
tion, depend on the structure, size, shape, and composition, and can be altered to manipulate
the magnetic properties. Particle size plays an important role in many magnetic biomaterial
applications such as magnetic hyperthermia and drug delivery, where the size used lies in the
nanometer regime. The MNPs often contain a layer of disordered spins on the surface of the
particle leading to reduction in their Ms compared to the corresponding bulk material. A
relation between theMs and the size of the nanoparticle is given by [25]
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Ms ¼ Msb
r d
r
 3
ð1Þ
where r is the radius of the nanoparticle, d is the layer thickness of the disordered spins, and
Msb is the saturation of the bulk material. Recent studies have shown that the functionalization
of MNP can reduce the thickness of the surface-disordered spin layer [26].
Although the effect of shape of MNP on their magnetic properties is not extensively studied, a
few investigations have been reported in the literature on ferrite nanocubes, maghemite
nanorods, NiFe wires, cobalt nanodiscs, tetrapods, and Au-MnO nanoflowers showing a
strong dependence of Ms on the shapes of the nanoparticles [27–36]. Higher Ms values have
been observed for the cubic MNP compared to the spherical MNP of the same size [37]. Also,
cubic Fe3O4 nanoparticles have been found to exhibit higher TB compared to spherical Fe3O4
nanoparticles [38], and the amount of disordered spins to be less (4%) in the former and more
(8%) in the latter [39].
Magnetic properties of widely usedmagnetite (Fe3O4) with its spinel structure of [Fe
3+]A[Fe
3+Fe2+]BO4
can be changed if other magnetic atoms such as Ni, Co, Mn, and so on are substituted at the
tetrahedral A or octahedral B sites of the spinel structure. This flexibility of creating mixed
ferrites is useful in tuning the magnetic properties for hyperthermia applications. There have
been numerous studies investigating the interdependence of magnetic properties and the
composition. The method of preparation, concentration and nature of dopants, and
postsynthesis processes have shown to profoundly affect the magnetic properties. A study [40]
compared the magnetization among the four spinels of FeFe2O4, MnFe2O4, CoFe2O4, and
NiFe2O4 for the same size of 12 nm and found the highest magnetization for MnFe2O4. In
another study with Y3Fe5-xAlxO12 for x varying between 0 and 2, the Curie temperature
changed from 40 to 280C [41]. With increasing Al, Fe3+ cations occupied the tetrahedral sites
and some of the octahedral sites of Fe2+ were replaced by nonmagnetic Al3+ cations, which
reduced the magnitude ofMs. The Tc value reached the room temperature for x value between
1.5 and 1.8. The variation in composition affects not only the magnitude of Ms but also the
coercivity. The tailoring of ferromagnetic to paramagnetic phase transition temperature is
particularly very useful in hyperthermia application to turn off undesirable heating beyond
the required temperature.
3. SPION synthesis and surface modification
Over the past decades, many efficient synthesis methods have been developed to produce the
size/shape controlled, stable, biocompatible, and monodispersed iron oxide nanoparticles [42–45].
The most common methods include coprecipitation [46, 47], thermal decomposition [48], hydro-
thermal synthesis [49, 50], microemulsion [51], and sonochemical [52] synthesis. Thermal decom-
position technique involves decomposition of organo-metallic iron precursors in organic solvents
at higher temperatures. Although the method can produce high-quality monodisperse particles
because of separate nucleation and growth processes, it is a complicated synthesis method and
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produces hydrophobic nanoparticles that cannot be directly used for bio-applications without
laborious postsynthesis processes, which may result in aggregation and loss of magnetic
properties. The most commonly used technique is the coprecipitation method, which is a
cost-effective and a facile synthesis method. However, this method produces Fe3O4
nanoparticles with wide particle size distribution due to lack of control over hydrolysis reac-
tions of the iron precursors, and the nucleation and growth steps leading to particles with a
range of superparamagnetic-blocking temperature. The other common, recently developed,
method is the hydrothermal synthesis, which generates nanoparticles with excellent crystal-
linity with controllable size and shape in aqueous phase. The properties of the nanoparticles
can vary with the synthesis method due to the differences in cationic distribution and
vacancies, spin canting, or surface contribution.
In the design of magnetic nanoparticles for theranostic applications, surface modification plays
an important role in providing colloidal stability and biocompatibility. The stable colloidal
suspensions of surfactant-coated SPION are called “ferrofluids” which are magnetizable and
remain as liquids in the presence of magnetic fields and in biological media. Stabilization of the
ferrofluid occurs in the presence of one or both of the two repulsive forces (see Figure 2). The
electrostatic repulsion can be understood through the knowledge of the diffusion potential and
mainly depends on the ionic strength and the pH of the solution. The steric force is difficult to
predict or quantify and mostly depends on the weight and the density of the polymer used for
the coating.
In order to achieve biocompatibility, the coating should prevent any toxic ion leakage from
magnetic core into the biological environment as well as shielding the magnetic core from
oxidation and corrosion. When nanoparticles are injected into the body during in vivo appli-
cations, they are often recognized by reticuloendothelial system (RES) that eliminates any
foreign substance from blood stream [53]. In this process, nanoparticles are rapidly attacked
by the plasma proteins from RES and shuttled out of circulation to the liver, spleen, or kidney,
Figure 2. Electrostatic and steric repulsion between the particles.
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which are then cleared out from the body. Also, this RES accumulation often causes toxicity
issues as well. The specific surface coatings can prevent the adsorption of these proteins,
increasing the circulation time in blood, hence maximizing the possibility to reach target
tissues [54]. For instance, it is well known that coating of hydrophilic polymers, mainly
polyethylene glycol (PEG), on the nanoparticles reduces nonspecific binding of the proteins
resulting in stealth behavior. In addition to the stabilization and enhanced biocompatibility,
these protecting shells also provide a platform for further functionalization such as the addi-
tion of specific targeting ligands, dyes, or therapeutic agents.
Over the years, researchers have developed various surface modification strategies com-
posed of grafting of or coating with both organic and inorganic materials. Organic molecules
include small organic molecules, macromolecules or polymer and biological molecules. They
provide various highly reactive functional groups such as carboxyl groups, aldehyde
groups, and amino groups. Polymer-coating materials can be classified into synthetic and
natural, and some commonly used polymers are listed in Table 1 along with their advan-
tages.
The surface coating could affect the magnetic properties of SPION. Many studies have reported
the effect of the surfactants on the magnetic properties [55–60]. Yuan et al. [58] investigated the
effect of surfactant on magnetic properties using commercially available aqueous nanoparticle
suspensions, FluidMAG-Amine, FluidMAG-UC/A, and FluidMAG-CMX, in parallel with oleic
acid-covered particles suspended in hexane and heptane. Their results reveal the reduction of
magnetic phase in nanoparticles, which varies with different coatings as well as with solvents.
The reduction in magnetization with different coatings was attributed to the different degree of
surface spin disorder.
Polymer Advantages and applications References
Natural Dextran Stability, biocompatibility, enables optimum polar interactions with
iron oxide surfaces, and enhances the blood circulation time
[61–66]
Starch Improves the biocompatibility, good for MRI, and drug target delivery [67, 68]
Chitosan Biocompatible and hydrophilic large abundance in nature,
biocompatibility, and ease of functionalization. widely used as nonviral
gene delivery system
[69–72]
Synthetic Poly(ethylene-glycol)
(PEG)
Enhances the hydrophilicity and water-solubility, improves the
biocompatibility, blood circulation times, and internalization efficiency
of the nanoparticles. Used in target-specific cell labeling, magnetic
hyperthermia, targeted drug delivery
[73–75]
Alginate Improves the stability and biocompatibility. Used in drug delivery
applications
[76–78]
Poly-N-isopropyl-
acrylamide (PNIPAM)
Generally used as thermosensitive drug delivery and cell separation [79–82]
Polyethylene-imine
(PEI)
Ability to complex with DNA, guide intracellular trafficking of their
cargo into the nucleus, used for gene delivery cell transfection with
either DNA or siRNA nucleotides
[83–86]
Table 1. Commonly studied organic polymers and their advantages.
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4. SPION for drug delivery
Over the last two decades, MNPs have been increasingly exploited as platforms for the
transport of therapeutics including drugs and genes [46, 87, 88]. In magnetic drug delivery, a
drug or a therapeutic reagent is conjugated to the nanoparticle and introduced in the body, and
concentrated in the target area by means of a magnetic field gradient (using an internally
implanted permanent magnet or an externally applied field) [89]. Even though magnetic drug
delivery shows a great promise in cancer treatment avoiding the side effects of conventional
chemotherapy, the designing and fabrication of an efficient nanoparticle-based drug delivery
system is still a challenge. Using a targeting ligand, the targeting specificity can be enhanced.
These anticancer drugs carried by the nanoparticles can then be released at the tumor site via
enzymatic activity, or via changes in the physiological conditions such as temperature and pH.
Drug release can also be magnetically triggered from the drug-conjugated magnetic nano-
particles [89–91]. For example, Hayashi et al. [92] reports a study done on superparamagnetic
iron oxide nanoparticles conjugated with folic acid (well known as a targeting ligand for breast
cancer cells), β-Cyclodextrin (which acts as drug container), and Tamoxifen (anticancer drug).
Using an AC magnetic field, heat is generated which triggers drug release—a behavior that is
controlled by switching the high-frequency magnetic field on and off. This is capable of
performing drug delivery and hyperthermia simultaneously. Among various other anticancer
drugs, Doxorubicin (Dox) is widely used as a model drug. There are several methods that can be
used to load Dox into nanoparticles, such as by adsorption onto nanocarrier inorganic
core [93–95], by diffusion [95, 96], or entrapment [97, 98] in the coating materials and by chemical
bonds [99, 100] with the coating of the nanocarrier. Several modifications including surface
functionalization of these SPIONs with Dox have been conducted over the last few years to
investigate their efficacy [101]. Previous studies have reported that PEG-functionalized porous
silica shell onto Dox-conjugated Fe3O4 nanoparticle cores [102], PAMAM (Poly(amidoamine))-
coated Fe3O4 nanoparticles-Dox complex [103], and Dox-loaded Fe3O4 nanoparticles modified
with PLGA-PEG copolymers [104] could potentially be very promising in therapeutic cancer
treatment. However, most of the Dox-SPION–based drug delivery studies have been focused on
human breast cancer cells.
In our recently published work [105], we have developed a novel drug delivery platform based
on Fe3O4 nanoparticles as a vehicle for an anticancer drug (Dox), attached to a model dye
(FITC) for their precise tracking and investigated their incorporation into the human pancre-
atic cancer cell line (MIA PaCa-2) for specific drug targeting. Existing EDC/NHS technique was
employed for this dual drug/dye conjugation. This unique drug-dye dual conjugation of
SPION after penetration through the cell membrane shows a steady release of Dox into the
nucleus of the malignant cells. Our studies demonstrate that the association of Dox onto
the surface of nanoparticles enhances its penetration into the cancer cells as compared to the
unconjugated drug as shown in the subsequent text (Figure 3). In addition to the rapid uptake
of these SPIONs by live cells, our results also suggest that upon entering the cells, Dox is
cleaved from the conjugation, which might be due to the enzymatic reactions that occur within
the cells, and tends to accumulate in the nuclei fulfilling the major requirement for an effective
therapeutic system.
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5. SPION for cancer diagnosis using MRI
Magnetic resonance imaging with its high spatial resolution has been a preferred method of
imaging and diagnosing a disease. It is a noninvasive medical diagnostic tool that monitors the
change in magnetization of hydrogen-protons in water molecules contained in a tissue when
placed in a magnetic field and exposed to a pulse of radio frequency electromagnetic waves.
The mapping of the magnetization provides an image of the organ due to the fact that protons
in different tissues, with varying water concentration, respond differently. Contrast agents
have been used to enhance the images as they affect the behavior of the protons in their vicinity
leading to sharper images. Contrast agents used in MRI are divided into two categories: T1 and
Figure 3. (A) Phase and fluorescent micrograph of MIA PaCa 2 cells incubated with Dox. Note the cellular entry,
especially into the nucleus (red fluorescence), of the free drug 6 h following exposure. The inset shows blebbing of cells
exposed to Dox prior to cell death (Scale = 20 μm). (B) Phase and fluorescent micrograph of MIA PaCa 2 cells incubated
with free Dox and free FITC (control) and Dox-FITC-conjugated Fe3O4 NPs at 15 min. Green and red fluorescence
represent FITC and Dox, respectively. Note the accumulation of Dox in the nucleus in cells exposed to the Dox and
FITC-conjugated SPION. White arrowheads indicate Dox entry into the nucleus. Reprinted from Ref. [105], Copyright
(2017), with permission from Elsevier.
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T2 contrast agents based on their effect on the magnetic relaxation processes of the pro-
tons [106]. Most commonly used T1 contrast agents are paramagnetic compounds that are
composed of metal ions of Gd3+ or Mn2+ and a chelating ligand, such as diethylene triamine
penta-acetic acid, DTPA [106, 107]. The chelate prevents the metal ion from binding to chelates
in the body making the paramagnetic ion less toxic. T1 contrast agents mainly reduce the
longitudinal relaxation time (T1) which is due to energy exchange between the spins and
surrounding lattice (spin-lattice relaxation) and result in a brighter signal. T2 contract agents,
consisting of superparamagnetic nanoparticles such as Fe3O4, have a strong effect on the
transverse relaxation time (T2). In an external magnetic field, nanoparticles are magnetized
and generate induced magnetic fields locally. These induced fields perturb the magnetic
relaxation processes of the protons in the water molecules decreasing the T2 relaxation time,
which results in darkening of MR images.
There are various research studies conducted on enhancing the MRI signal for cancer detection
using SPIONs as T2 contrast agents [108–110]. The efficiency of SPIONs as T2 contrast agents
mainly depends on their physicochemical properties, particularly their size and surface chem-
istry. Stephen et al. [111] report the correlation between particle size and T2 relaxation. Their
study shows that a decrease in particle size leads to reduction in saturation magnetization,
which in turn reduces the T2 relaxation capabilities of SPIONs. There are studies which show
the effect of shape on relaxivity. For example, Zhen et al. [112] reported that cubic Fe3O4 MNP
showed four times smaller relaxation time and thus better image contrast compared to the
spherical Fe3O4. In another study, octapod Fe3O4 nanoparticles with an edge length of 30 nm
show a smaller value of T2 compared to 16-nm spherical Fe3O4 nanoparticles possessing a
similarMs [37]. The studies by Park et al. [113] report a decrease in relaxivity as PEG molecular
weight increases, indicating that the thickness of PEG coating at the particle surface affects T2
relaxivity.
When using SPIONs as contrast agents for MRI, it is crucial that they are captured into the cells
efficiently upon exposure. Some approaches include introducing peptides [114], anti-
bodies [115], and polymers [116] onto or surrounding magnetic nanoparticles to improve the
target specificity. For example, Jun et al. [117] have successfully synthesized superparamagnetic
iron oxide nanoparticles of 9-nm size as magnetic probes for the in vivo detection of cancer cells
implanted in a mouse. In their research work, 2,3-dimercaptosuccinic acid (DMSA) ligand is
attached to the nanoparticles surface to obtain hydrophilic nanoparticles and the nanoparticles
are further conjugated with the cancer-targeting antibody, Herceptin. The specific binding prop-
erties of Herceptin against a HER2/neu receptor overexpressed from breast cancer cells lead to
the successful detection of breast cancer cells (SK-BR-3).
Even though both T1 and T2 mapping are powerful techniques, single-mode contrast agents are
not always sufficient in modern diagnosis as they have certain drawbacks and limitations [118].
For example, thedark contrast producedbyT2 agents canalso begenerated fromadjacent bonesor
vascular or there can be susceptibility artifacts due to the sharp change in magnetic field at the
surrounding contrast agent. Also, Gd-chelates (T1 agent) have high mobility which shorten their
presence in the vascular system and raise possible toxicity issues. Thus, there is a growing interest
in developing complementary T1-T2 dual-modal contrast agents, combining the advantages of
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positive and negative contrasts to obtain high sensitivity and biocompatibility for improved
diagnosis [119]. Two different approaches of integrating T1 and T2 species have been reported
recently [118]. One is constructed by labeling T1-signaling elements (Gd species) on magnetic
nanoparticles. In the study done by Bae et al. [120], Gd-DTPA, a representative Gd chelate-based
T1MRI contrast agent, is covalently attached to dopamine-coated iron oxide nanoparticles. Their
results demonstrated that the composite not only had the ability to improve surrounding water
proton signals on the T1-weighted image but also could induce significant signal reduction on the
T2-weighted image. In another study reported by Santra et al. [121], Gd-DTPA is encapsulated
within the poly (acrylic acid) (PAA) polymer-coated SPION (IO-PAA) conjugated to folic acid,
which acts as the targeting ligand for breast cancer cells (HeLa cells). When nanoprobes are
internalized within the cells, which is acidic, composite magnetic nanoprobe degrades resulting
in an intracellular release of Gd-DTPA complex with subsequent T1 activation, which can be seen
byMRI.Authors claim that thisT1nano-agent couldbeused for thedetectionof acidic tumors. The
other type of conjugated system consists ofT1 paramagnetic elements embedded intoT2magnetic
nanoparticles. For example, Zhou et al. [122] have synthesized Gd2O3-embedded iron oxide
nanoparticles with an overall size of 14 nm which can act as a T1-T2 mutually enhanced dual-
modal contrast agent for MR imaging of liver and hepatic tumor detection with great accuracy in
mice. Xiao et al. [123] have prepared PEGylated, Gd-doped iron oxide nanoparticles which is
applicable as a T1-T2 dual-modal MRI contrast agent. Their in vivo MRI results demonstrated the
simultaneous contrast enhancements in T1- and T2-weighted MR images toward the glioma-
bearingmice.
6. SPION for cancer therapy using magnetic hyperthermia
Magnetic hyperthermia is the transformation of electromagnetic energy from an external
alternating magnetic field into heat using MNP. Magnetic nanoparticles serve as the nano-
heat centers producing heat by relaxation losses, thereby heating the tissue. The main goal of
an effective cancer treatment is to kill the malignant cells with the least of damage to normal
cells. As MHT can be used for heating small regions selectively, it offers the potential for being
highly selective and noninvasive technique for therapeutic treatment of cancers, and conse-
quently it has advantage over other treatment such as chemotherapy and radiation therapy. It
is known that reduced blood flow in tumor causes the lack of oxygen in tumor site which leads
to the formation of lactic acid making the cells more acidic [124]. The acidic cells are more
sensitive to temperature, have lower thermal resistance than normal cells, and the decreased
blood flow in the tumor limit their ability to dissipate heat. As a result, cancer cells can be
damaged or killed by increasing the local temperature to the range of 42–46C with little
detriment to healthy cells.
The idea of utilizing SPION for hyperthermia was first proposed by Gilchrist et al. [125] in
1950s and since then many types of MNP are being investigated for this purpose. MNPs have
the advantage of being guided and localized specifically at a tumor site by external magnetic
fields and can also be directed to the cancer cells by tagging a ligand, such as an antibody or a
peptide, without reducing its efficiency. For example, Fabio et al. [126] have reported that
the conjugation of folate receptors enhances the targeting for magnetic hyperthermia in solid
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tumors. Magnetite (Fe3O4) and maghemite (γ-Fe2O3) have been extensively studied and are
promising candidates due to their biocompatibility and relative ease for functionalization.
Additionally, iron oxide nanoparticles doped with other magnetic dopants such as Co, Mn,
and Ni [127–129] are under investigation to achieve a high heating efficiency by tuning the
magnetic anisotropy and saturation magnetization of the material. In addition, many recent
findings show that multicore nanoparticles possess a higher heating power than the single-
core particles [130], and may offer an advantage. However, among numerous complications,
with a high Curie temperature of Fe3O4, 850 K, and γ-Fe2O3, 750 K, overheating is one of the
drawbacks of utilizing these nanoparticles, and as a solution, those complex magnetic oxides
with low Curie temperature are being investigated [131–133].
Specific absorption rate (SAR) is a measure of efficiency of heat generation. The SAR value can
be estimated by measuring the temperature change in the ferrofluid samples upon exposure to
an AC magnetic field following the equation [134]:
SARðTÞ ¼ Msample
mFe3O4
C
ΔT
Δt
 
T
ð2Þ
Here,Msample is the mass of the sample, mFe3O4 is the mass of Fe3O4 nanoparticles in the sample,
C is the specific heat capacity of the sample, and dTdt
 
T
is the time rate of change of temperature at
T obtained from the slope of the time-dependent temperature data. SAR depends on magnetic
properties of the particles such as Ms, anisotropy constant K, particle size distribution (σ),
magnetic dipolar interactions, and the rheological properties of the target medium. An ensemble
of poly-disperse particles is usually described by a log-normal distribution function,
f ðDÞ ¼ 1ffiffiffiffiffiffi
2π
p
σD
exp  ½lnðD=D∘Þ
2
2σ2
 
ð3Þ
Here, Do is the most probable particle diameter and σ is the width of the distribution. The
temperature-dependent average power dissipation in the sample is expressed as [135]
PðTÞ ¼
ð
∞
0
μ0χ0H
2
0ω
2
ωτef f
1þ ðωτef f Þ2
f ðDÞdðDÞ ð4Þ
where Ho and ω are the amplitude and angular frequency of the applied AC magnetic field, μo
is the vacuum permeability, τeff is the effective relaxation time involving Néel relaxation and
the Brownian relaxation times, and χo is equilibrium susceptibility. τeff is defined as
1
τeff
¼ 1τN þ 1τB, where τB ¼
4πηR3H
kBT
and τN ¼
ffiffi
π
p
2 τ0 exp
KV
kBT
	 
 ffiffiffiffiffiffi
KV
kBT
q
are the Néel and Brownian relax-
ation times, η is the viscosity of the suspension, RH is the hydrodynamic radius of the coated
nanoparticle, Vm is the magnetic volume of the nanoparticles, and τo ~ 10
9 s. χo is given by
χo ¼ χi cothξ 1ξ
	 

, where χi ¼ μ∘φM
2
dH∘Vm
3kbT
is the initial susceptibility, and ξ ¼ μ∘MdH∘VmkbT , with Md
being the domain magnetization of the nanoparticle and φ the volume fraction of the magnetic
nanoparticles in the ferrofluid. SAR in units of W/g is obtained using Eq. (4) as PðTÞ=mFe3O4 ,
where mFe3O4 is the mass of Fe3O4 nanoparticles in ferrofluids.
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MHT investigations are often done on colloidal suspensions of surface-coated MNP, called
ferrofluids. It is often necessary to coat the MNP using a biocompatible polymer to avoid direct
contact with the tissue and to reduce the particle aggregation. Ferrofluid preparations fre-
quently yield a mixture of isolated nanoparticles and nanoclusters [136] with varying degree
of magnetic dipole-dipole interactions present in ferrofluids. It has been shown that the dipolar
interactions among the MNP affect the SAR value drastically and can be exploited to optimize
SAR [136–139]. A mean-field approximation method has been used to account for effects of
interactions on SAR for a collection of monodisperse MNP [138, 139], and we have used this
approach to explain the very different observed SAR values for similar size particles prepared
by two different methods of preparation [140].
Since the surfactant influences the magnetic properties as well as the degree of interactions in
the ferrofluid, a useful approach for improving the magnetic hyperthermia performance is to
optimize the surface coating to maximize the SAR. Currently, there are conflicting SAR values
obtained for a certain sized nanoparticle making it difficult to evaluate the exact contributions of
surface coating on the SAR. According to Mohammad et al. [141], it is found that inorganic
coatings improve the SAR value and the gold coating retains the superparamagnetic fraction of
Fe3O4 nanoparticles much better than uncoated nanoparticles alone and leads to higher
magnetocrystalline anisotropy. A study by Liu et al. [142] suggested the possibility of increasing
SAR by decreasing the surface-coating thickness using highly monodispersed Fe3O4
nanoparticles with different polyethylene glycol-coating thickness. The increase in SAR was
explained as due to a decrease in coating thickness leading to an increased Brownian loss,
improved thermal conductivity, as well as improved dispersion. It should be noted that the
heating performance of the nanoparticles depends on the medium as well. Whenever
nanoparticles encounter biological systems, interactions take place between their surfaces and
biological components such as proteins, membranes, phospholipids, and DNA forming the so-
called protein corona around the nanoparticles [143, 144]. The formation of corona depends on
the surface properties of the particles [145, 146] and can influence the aggregation behavior of
nanoparticles in biological media, which in turn can affect their performance for desired appli-
cations. Therefore, apart from the optimization of the properties of the magnetic core and surface
coating for high-performance MHT, it is necessary to ensure its performance in the physiological
environments.
In the work reported by Khandhar et al. [147], authors use poly(maleic anhydride-alt-1-
octadecene)-poly(ethylene glycol) (PMAO-PEG), an amphiphilic polymer-coated Fe3O4
nanoparticles of three different sizes, 13, 14, and 16 nm, to study the MHT efficiency in cell
growth medium (CGM) similar to biological environment. Their results showed an increase in
hydrodynamic sizes in all three samples upon exposure to CGM. SAR reduced (30%) only in
16-nm size sample, while other two samples did not exhibit any significant decrease in SAR.
The authors suggest that the increase in hydrodynamic volume prolongs Brownian relaxation
while Néel relaxation is unaffected. Hence, in 13- and 14-nm samples where SAR is mainly due
to Néel relaxation, SAR was not affected. But in the 16-nm samples, in which there is a
contribution from Brownian relaxation to heat dissipation, the SAR dropped due to the
increase in Brownian relaxation. We have investigated the magnetic hyperthermia efficiency
of dextran and citric acid (CA)-coated Fe3O4 ferrofluids in cell growth medium, which contains
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serum proteins similar to physiological environments. From the stock solutions (25 mg/ml), 3
mg/ml concentration of dextran and citric acid-coated ferrofluids samples were prepared using
CGM and deionized water (DI) water. The ferrofluid samples were subjected to an AC field of
235-Oe amplitude at the frequency of 375 kHz. The SAR of dextran-coated samples in DI and
CGM was estimated to be 63 and 72 W/g, which indicates that their performance is not much
affected by the medium if not enhanced. However, SAR values obtained for CA-coated sam-
ples in DI and CGM, 78 and 38 W/g, implies that their efficiency is heavily reduced when
exposed to physiological environments.
7. Gd-doped SPION as a potential theranostic agent
The multifunctionality of SPION makes them a good candidate for theranostics. One such
approach to integrate diagnostic imaging and therapeutic function is to develop SPION as an
MRI/a drug delivery platform. Yu et al. [148] reported that PEG-coated iron oxide nanoparticles
when loaded with Dox provide a therapeutic capability. Following their injection into a mouse,
Dox-modified magnetic nanoparticles accumulate in the tumor and the nanoparticles were
imaged by using T2 MRI. The contrast associated with the tumor changes from light to dark at
4.5 h post injection and the growth rate of the tumor mass was decreased in the nanoparticle-
injected mice compared to that of a control group. In another work, Lee et al. [149] developed
PEG-stabilized Fe3O4 nanocrystals on dye-doped mesoporous silica nanoparticles and Dox
was loaded into the pores. Here, SPIONs work as a contrast agent in MRI, the dye molecule
imparts optical imaging modality, and Dox induces cell death. In a similar approach, Kim et al.
[150] developed a core-shell structure consisting of single Fe3O4 core and mesoporous silica
shell for MR and fluorescence imaging which also has the potential to be used as a drug carrier.
Hayashi et al. [92] reports a study done on SPION conjugated with folic acid as targeting
ligand and Tamoxifen as anticancer drug. The drug release was triggered by heat generated
by SPION in an AC magnetic field, hence performing drug delivery and hyperthermia simul-
taneously.
The incorporation of MHT and imaging modalities [151] has been investigated widely as well.
One such study is reported by Hayashi et al. [152] in which authors have investigated SPION for
cancer theranostics by combining MRI and magnetic hyperthermia through a set of in vivo
experiments. They show that FA- and PEG-modified SPION nanoclusters accumulated locally
in cancer tissues within the tumor and enhanced the MRI contrast. Furthermore, they report that
with MHT, the tumor volume of treated mice was reduced to one-tenth that of the control mice.
Also, Gd-doped Fe3O4 nanoparticles have the potential to act as an effective MHTagent [153] in
addition to their use as a T1-T2 dual-modal contrast agent for MR imaging. Gd(III) is known to
oppose net magnetic moment of Fe(III)/Fe(II) in oxides, reducing magnetization [154–156].
Therefore, Gd doping may reduce the hyperthermia efficiency, but by using the correct amount
of doping, one can always explore the possibility of using them as both MRI contrast agents and
hyperthermia mediators. However, there are very few studies done on theMHTefficiency of Gd-
doped Fe3O4 nanoparticles [157, 158]. Both the studies report higher SAR values for Gd-doped
Fe3O4 nanoparticles compared to the reported values for undoped samples. In our work presented
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here, we have investigated the MHT efficiency of Gd0.075Fe2.925O4 nanoparticles for possible use as
a theranostic agent.
7.1. Synthesis and characterization of Gd-doped SPION
Gd0.075Fe2.925O4 nanoparticles were synthesized by coprecipitation method. For a typical syn-
thesis of Gd0.075Fe2.925O4, aqueous solution of FeCl2.4H2O, FeCl3.6H2O and Gd(NO3)3 was
mixed in a molar ratio of 1.00:1.925:0.075 in 25-ml volume followed by the addition of 250 ml
of 1 M NH4OH. The synthesized nanoparticles were then coated with dextran according to the
method outlined by Arachchige et al. [140]. From the structural investigation, it was observed
that Gd doping does not alter the Fe3O4 crystal structure significantly (Figure 4). Using several
intense X-ray diffraction (XRD) peaks and the Debye-Scherer equation, the crystallite sizes of
the Fe3O4 and Gd0.075Fe2.925O4 nanoparticle samples were determined to be 11.7  0.6 and
14.9  0.5 nm, respectively. This increase in the crystallite size is consistent with the previous
studies on Gd doping in spinel structures [159].
TEM images of the two samples are shown in Figure 5. The undoped sample consists of
roughly spherical nanoparticles with smaller polydispersity, whereas the Gd-doped sample
exhibits nanoparticles with rough edges with wider size distribution.
The magnetic properties of the synthesized powder as well as the ferrofluid samples are
determined by analyzing the M(H) curve. The M-H data for undoped and Gd-doped Fe3O4
ferrofluid samples, recorded at room temperature, are shown in Figure 6. The sigmoidal
shape of the M(H) curves with nearly zero hysteresis confirms the superparamagnetic
nature of these nanoparticles at room temperature. The saturation magnetization of Fe3O4
nanoparticles is measured to be ~72 emu/g, whereas that of Gd-doped Fe3O4 nanoparticles is
reduced to ~52 emu/g. This reduction in saturation magnetization at room temperature
agrees with the observations in other reported studies [123, 158] and can be attributed to
the fact that magnetic Fe3+ ions get replaced by the Gd3+ ions in the octahedral sites of the
inverse spinel structure.
Figure 4. X-ray diffraction patterns of as-prepared Fe3O4 and Gd0.075Fe2.925O4 nanoparticles [160].
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It is observed that the doping of Gd3+ ions into Fe3O4 spinel has significantly influenced the
average crystallite size and the saturation magnetization. The M(H) curve for an ensemble of
noninteracting superparamagnetic nanoparticles described by a log-normal distribution func-
tion, f(D), can be fitted using the following expression:
MðHÞ ¼Ms
ð
∞
0
f ðDÞVLðxÞdD
ð
∞
0
f ðDÞVdD
ð5Þ
where LðxÞ ¼ coth x 1x is the Langevin function, x ¼ ðMsVHÞ=kBT, Ms is the saturation mag-
netization, and V is the volume of the particle. The fitted particle size was inconsistent with the
Figure 5. TEM images of (a) Fe3O4 and (b) Gd-Fe3O4 nanoparticles [160].
Figure 6. M versus H curves for two ferrofluid samples fitted with Eq. (5). The inset shows the resulting particle size
distribution obtained for the two samples [160].
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observed XRD data, and it was necessary to introduce the magnetic dipolar interaction effects
through a phenomenological temperature, T*, as described in our recent work [140]. The best-
fit parameters for the two samples are shown in Table 2, and Figure 6 shows the fitted data.
The inset in Figure 6 shows the magnetic core size distributions for two ferrofluid samples. The
fitting of M(H) data with Eq. (5) clearly shows that Gd-doped Fe3O4 nanoparticles have a
higher average magnetic core size with a larger size distribution (14.6  3.7 nm) and lower
saturation magnetization (52 emu/g) compared to the undoped Fe3O4 nanoparticles (11.7  1.9
nm, 72 emu/g). Both the ferrofluid samples exhibit similar strength of magnetic dipolar inter-
action (T* ~80–100 K).
MHT measurements were carried out on the dextran-coated Gd-doped as well as undoped
Fe3O4 ferrofluid samples at a field of 235 Oe and at a frequency of 375 kHz. The heating
curves for two samples are shown in Figure 7(a), and from the plot it can be observed that
the initial heating rates for the two samples are approximately the same. From these heating
curves, the SAR values were obtained as a function of temperature taking into account heat
loss as described elsewhere [134]. Figure 7(b) presents the corrected experimental SAR
data as a function of temperature for both the undoped and Gd-doped samples. Within the
experimental error, the room temperature SAR values for Gd-doped Fe3O4 and undoped
Figure 7. (a) Heating profiles of Fe3O4 and Gd-doped Fe3O4 ferrofluid samples under an AC magnetic field amplitude of
235 Oe and at a frequency of 375 kHz. (b) The temperature dependence of net SAR for two ferrofluid samples. The black
line shows the theoretical fitting of the experimental data with the linear response theory [160].
Ferrofluid sample Ms (emu/g) Do (nm) σ T
* (K) Davg (nm)
Fe3O4 72 11.6 0.15 80 11.7  1.9
Gd -Fe3O4 52 14.2 0.23 100 14.6  3.7
Table 2. Fitting parameters obtained from the M(H) fitting with modified Langevin function using T*.
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Fe3O4 ferrofluid are very similar. The temperature-dependent SAR values were fitted to the
linear response theory incorporated with the interactions and size distribution [140]. The
solid lines in Figure 7(b) are the best fits to the experimental SAR data, using the particle size
distribution parameters and T* values given in Table 2 and treating the anisotropy constant,
K, as a fitting parameter. The SAR fitting yields a somewhat smaller anisotropy constant
(~12 kJ/m3) for Gd-doped ferrofluid compared to that of undoped ferrofluid (~21kJ/m3). It is
interesting to note that both samples have similar SAR values in spite of a smaller anisotropy
constant and the saturation magnetization for the Gd0.075Fe2.925O4 sample compared to the
undoped sample. The expected lowering of SAR in Gd0.075Fe2.925O4 is probably offset by a
larger particle size in this sample, as the SAR would increase with increasing particle size up
to a critical size [140]. By fine-tuning the composition of Gd-doped Fe3O4 nanoparticles, we
may achieve a higher SAR value.
In summary, the Gd doping on the Fe3O4 nanoparticles affects the morphology and the
magnetic properties of Fe3O4 nanoparticles considerably but the magnetic hyperthermia
efficiency of the samples was about the same within the experimental uncertainties. The
possibility of using Gd-doped Fe3O4 nanoparticles as a dual-modal T1-T2 contrast agent is
being currently explored by others and our magnetic hyperthermia results demonstrate
that this material is a potential candidate for multimodal contrast imaging and cancer
treatment by hyperthermia. However, further research is necessary to optimize the
amount of Gd doping to enhance SAR for cancer treatment and to be used as a theranostic
agent.
8. Conclusions
In this chapter, we have discussed various approaches to exploit the multifunctionality of
SPION for cancer theranostics. We have given a brief background on the nanoparticle
magnetism, followed by a description of commonly used synthesis methods and surface-
functionalizing strategies. Three major applications of Fe3O4 nanoparticles in drug delivery,
MRI, and MHT, including our recent work on Gd-doped SPION as a possible theranostic
agent, are described. This chapter also addresses the recent work on integrating the indi-
vidual diagnostic and therapeutic approaches to develop SPION-based theranostic plat-
form.
Despite the exciting progress, SPION is far from meeting clinical standards as theranostic
agent. It has its own promises and advantages, but there are still some disadvantages to be
overcome. These include target specificity as drug carriers, optimizing the heating efficiency
and aim for sufficient heating using minimum dosage, preventing the overheating in MHT,
and issues of biocirculation, biodistribution, and bioelimination within the biological system.
In summary, although in theory, SPION is a perfect vehicle in the development of theranostic
nanomedicine, more research is required to overcome its disadvantages and this should be the
main focus of the next stages of investigation.
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9. Future directions
In recent years, the research in the field of theranostics has brought many diverse fields
together for targeting, imaging, and therapy for a deadly disease like cancer. These fields
include physics of magnetism, chemistry of synthesis, material science of structure-
property relationship, surface science for functionalization, biomedical engineering in
MRI and radiofrequency activation and treatment, and biology for understanding the
behavior of cancer cells. SPIONs have played a key role in this application as visual,
imaging, and therapeutic agent. Several studies have shown promising results; however,
many challenges still remain in moving theranostic applications from laboratory settings
to clinics. Two major challenges we face are low efficacy and toxicity of SPION. For
in vivo applications, the amount of SPION used (several hundred microgram/ml) usually
produces undesirable toxic side effects. The smaller concentration, on the other hand, is
not sufficient for imagining and therapeutic action of the material. It is well known that
the size, shape, and surface modifications influence the performance of SPION. There is
a lack of information about the combined effects of these parameters in the clinical
applications. Also, we do not have a clear understanding of controlling the delivery of
SPION to a specific target in the body by using external magnetic field gradient. It has
been found that some particles would end up accumulating in other parts of the body
such as liver, spleen, kidney, and lungs along with the specific intended location. We do
not know how they will affect those nonspecific organs and how long they will stay
there. In magnetic hyperthermia therapy, measuring precise temperature at the tumor
site and adjusting particle properties with frequencies and amplitude of the external
field for apoptosis/necrosis of cancer cells without affecting normal tissues are challenges
that researchers and clinicians face every day. There have been promising results in
treating prostate and skin cancers with magnetic fluid hyperthermia but no real efforts
have been made to treat deep tumors such a pancreas and liver with SPION. In order to
make progress with these therapies, research is needed in the development of new
materials that have higher reflexivity, better thermal activation properties, and have
better coating materials to improve the bio-distribution and biocompatibility for in vivo
applications. Most imperatively, we need data on large animal studies before theranostics
can make a fruitful transition from research laboratories to the clinics, and so on.
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